208 related articles for article (PubMed ID: 32087236)
1. Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP).
Katsiki N; Mikhailidis DP; Bajraktari G; Miserez AR; Cicero AFG; Bruckert E; Serban MC; Mirrakhimov E; Alnouri F; Reiner Ž; Paragh G; Sahebkar A; Banach M;
Pharmacol Res; 2020 May; 155():104719. PubMed ID: 32087236
[TBL] [Abstract][Full Text] [Related]
2. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
3. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
4. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
[TBL] [Abstract][Full Text] [Related]
5. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.
Barkas F; Milionis H; Kostapanos MS; Mikhailidis DP; Elisaf M; Liberopoulos E
Curr Med Res Opin; 2015 Feb; 31(2):221-8. PubMed ID: 25418708
[TBL] [Abstract][Full Text] [Related]
6. Treatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responses.
Bonfim MR; Oliveira AS; do Amaral SL; Monteiro HL
Arq Bras Cardiol; 2015 Apr; 104(4):324-31. PubMed ID: 25993596
[TBL] [Abstract][Full Text] [Related]
7. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
Stock J
Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
[No Abstract] [Full Text] [Related]
8. Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice.
Arca M; Ansell D; Averna M; Fanelli F; Gorcyca K; Iorga ŞR; Maggioni AP; Paizis G; Tomic R; Catapano AL
Atherosclerosis; 2018 Apr; 271():120-127. PubMed ID: 29499359
[TBL] [Abstract][Full Text] [Related]
9. Statin intolerance.
Ahmad Z
Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
[TBL] [Abstract][Full Text] [Related]
10. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance.
Chien SC; Chen PS; Huang YH; Tang SC; Li YH; Yeh HI
J Formos Med Assoc; 2019 Oct; 118(10):1385-1392. PubMed ID: 30584005
[TBL] [Abstract][Full Text] [Related]
11. [Guidelines for the management of dyslipidemia].
Díaz Rodríguez Á;
Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
[TBL] [Abstract][Full Text] [Related]
12. [Statin intolerance and associated muscular dysfunctions].
Boulanger-Piette A; Bergeron J; Desgreniers J; Côté-Levesque M; Brassard D; Joanisse DR; Frenette J
Med Sci (Paris); 2015 Dec; 31(12):1109-14. PubMed ID: 26672664
[TBL] [Abstract][Full Text] [Related]
13. An assessment of statin safety by muscle experts.
Thompson PD; Clarkson PM; Rosenson RS;
Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
[TBL] [Abstract][Full Text] [Related]
14. Prescribing statin therapy in physically (in)active individuals vs prescribing physical activity in statin-treated patients: A four-scenario practical approach.
Gavilán-Carrera B; Soriano-Maldonado A; Mediavilla-García JD; Lavie CJ; Vargas-Hitos JA
Pharmacol Res; 2023 Nov; 197():106962. PubMed ID: 37866703
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).
Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pearson GJ; Pope J; Tashakkor AY
Can J Cardiol; 2016 Jul; 32(7 Suppl):S35-65. PubMed ID: 27342697
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of statin myopathy after statin withdrawal.
Armour R; Zhou L
J Clin Neuromuscul Dis; 2013 Mar; 14(3):103-9. PubMed ID: 23492461
[TBL] [Abstract][Full Text] [Related]
18. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
19. New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines.
Raygor V; Khera A
Curr Cardiol Rep; 2020 Jul; 22(9):87. PubMed ID: 32647997
[TBL] [Abstract][Full Text] [Related]
20. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
